Cite

HARVARD Citation

    Atsmon, J. et al. (2021). Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study. Vaccine. 39 (8), pp. 1328-1332. [Online]. 
  
Back to record